Corporate Vice President, Enterprise Account Leader, Asia Pacific, PAREXEL International
Emily is overall responsible for enterprise account leadership in Asia Pacific. Through developing clinical strategies and senior client relationships, she oversees pricing through to portfolio management for strategic partnerships and key accounts in Asia Pacific, in line with the commercial and business plan.
Emily joined PAREXEL in February 2015. As a business leader in the Asia Pacific region, she has held functional leadership roles in clinical operations, project and client management across countries in Asia, including China, Japan, Korea, Taiwan, Australia, India and Southeast Asia. She has over 20 years of management experience across phase I to IV in various therapeutic areas. With 11 years in leading pharmaceutical companies (AstraZeneca, Glaxowellcome and Pfizer) and 10 years in global CROs, Emily has a proven track record of cross-cultural leadership and surpassing client deliverables.
Prior to joining PAREXEL, Emily served as Vice President, Clinical Operations, Asia Pacific at inVentiv Health.
Emily holds a degree in Pharmacy (Honours) from the National University of Singapore, and an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine.